Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesEffective Treatment of Patients in a Deep Salvage Situation with Non-Active HAART: Experiences with the Expert Advice System RADATA
Infection, 11/04/09
Lorenzen T et al. – Despite extensive pre–treatment and multiple resistances against prescribed HAART, the patients demonstrated a decline in viral load and a stable CD4–cell count over the observation period. The activity of antiretroviral regimens is not exclusively explained by the current algorithms used for estimating antiretroviral drug activity.
Related Articles
Epidemiology and therapy of pain and depression during HIV and AIDS
Schmerz, 10/01/09
Relevance Score: 90%
Impact of Highly Active Antiretroviral Therapy (HAART) on AIDS and Death in a Cohort of Vertically HIV Type 1-Infected Children
AIDS Research and Human Retroviruses, 11/12/09
Relevance Score: 84%
Treatment partners and adherence to HAART in Central Mozambique
AIDS Care, 11/06/09
Relevance Score: 84%
Primary HIV infection
Practice Nursing, 10/13/09
Relevance Score: 84%
Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA
Journal of Clinical Virology, 10/06/09
Relevance Score: 84%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Taking the stress out of managing gout
Canadian Family Physician, 12/16/09
Responses to Continuous Glucose Monitoring in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections
Diabetes Technology & Therapeutics, 12/16/09
Immunosuppression Using the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus: Pilot Study Shows Significant Cognitive and Affective Improvement
Transplantation Proceedings, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor